Streetbeat News

Analyst Ratings

DHR

Danaher's (NYSE:DHR) short percent of float has risen 29.73% since its last report, with 6.33 million shares sold short, which is 0.96% of all regular shares available for trading. This increase in short interest can indicate a bearish market sentiment towards the stock. However, compared to its peers, Danaher has less short interest as a percentage of float, which is 4.68% on average.

Portfolio Pulse from Benzinga Insights

September 20, 2023 | 2:30 pm

PLTR

Palantir Technologies's (NYSE:PLTR) short percent of float has risen 14.52% since its last report, with 155.59 million shares sold short, which is 8.28% of all regular shares available for trading. This increase in short interest can act as an indicator of market sentiment towards a particular stock. Palantir's peer group average for short interest as a percentage of float is 3.01%, indicating the company has more short interest than most of its peers.

Portfolio Pulse from Benzinga Insights

September 20, 2023 | 2:30 pm

GSHD

TPG

UBS

WRB

Four financial stocks, Goosehead Insurance, Inc (GSHD), UBS Group AG (UBS), TPG Inc. (TPG), and W. R. Berkley Corporation (WRB), are considered overbought with their Relative Strength Index (RSI) values above 70, indicating they may be overvalued. GSHD was upgraded by BMO Capital with a raised price target. UBS is facing slow approvals in its takeover of Credit Suisse. TPG reported worse-than-expected Q2 results. WRB declared a special cash dividend.

Portfolio Pulse from Lisa Levin

September 20, 2023 | 2:20 pm

WEC

WEC Energy Group's (NYSE:WEC) short percent of float has fallen 5.03% since its last report, with 4.14 million shares sold short, which is 1.7% of all regular shares available for trading. It would take traders 3.84 days to cover their short positions on average. The company has less short interest than most of its peers, with the peer group average for short interest as a percentage of float being 2.05%.

Portfolio Pulse from Benzinga Insights

September 20, 2023 | 2:15 pm

BIIB

Biogen's (NYSE:BIIB) short percent of float has risen 3.39% since its last report, with 3.14 million shares sold short, which is 2.44% of all regular shares available for trading. It would take traders 5.06 days to cover their short positions on average. An increase in short interest can signal that investors have become more bearish. However, Biogen's peer group average for short interest as a percentage of float is 3.54%, which means the company has less short interest than most of its peers.

Portfolio Pulse from Benzinga Insights

September 20, 2023 | 2:15 pm

ADP

Automatic Data Processing's (NYSE:ADP) short percent of float has fallen 10.19% since its last report, with 3.99 million shares sold short, which is 0.97% of all regular shares available for trading. This decrease in short interest could indicate a more bullish market sentiment towards ADP. Compared to its peers, ADP has less short interest as a percentage of float, with an average of 5.77%.

Portfolio Pulse from Benzinga Insights

September 20, 2023 | 2:15 pm

WK

BMO Capital analyst Daniel Jester has maintained an 'Outperform' rating on Workiva (NYSE:WK) and raised the price target from $115 to $123.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 2:08 pm

DIS

Disney (NYSE:DIS) shares are struggling after multiple analysts lowered price targets following the company's Investor day. Disney announced plans to double investments in its Parks, Experiences and Products segment over the next decade to approximately $60 billion. Despite this, BofA Securities and Rosenblatt analysts maintained a Buy rating but lowered the price target, while Needham reiterated a Hold rating.

Portfolio Pulse from Adam Eckert

September 20, 2023 | 2:07 pm

XEL

BMO Capital analyst James Thalacker has maintained a 'Market Perform' rating on Xcel Energy (NASDAQ:XEL) but lowered the price target from $66 to $62.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 2:07 pm

TSHA

Truist Securities analyst Joon Lee has maintained a 'Buy' rating on Taysha Gene Therapies (NASDAQ:TSHA), but lowered the price target from $6 to $5.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 2:06 pm